Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-27

Clinical Trial Update: Linerixibat Compassionate Use for Cholestatic Pruritus Adult Patients With Primary Biliary Cholangitis (PBC)

View source ↗

Summary

This clinical trial update describes compassionate-use access to linerixibat for adults with cholestatic pruritus due to primary biliary cholangitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linerixibat (linerixibat)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pruritus | Status: AVAILABLE